Search

everythinglearnresearchcommunity

for

Search:↓

Mesotherapy is more effective than topical spray for female hair loss treatment.

Treat hair loss in postmenopausal women with diet, avoiding certain drugs, and using medications like minoxidil or finasteride.

Oral minoxidil is as effective and safe as topical minoxidil for treating female pattern hair loss.

Women with hair loss have weaker hair that breaks more easily.

A patient with a skin condition had unusual scarring hair loss but improved with treatment.

Understanding normal hair growth and loss in children is key to diagnosing and treating hair disorders.

Some drugs can cause reversible hair loss, but certain chemotherapy drugs may lead to permanent hair loss; drugs can also change hair color and texture.

Gender affects hair and scalp characteristics, with differences in hormone responses, graying patterns, and trace metals.

The document concludes that alopecia has various forms, each with specific treatments, but no definitive cure for certain types like CCCA has been proven.

The document explains various skin conditions and their treatments.

Orthognathic surgeons play a key role in modifying masculine facial features to be more feminine, often improving transgender women's quality of life.

Modern hair restoration techniques can effectively treat hair loss and provide natural-looking results.

Androgens and other hormones affect hair growth and skin conditions like acne.

Hair transplant works well, but needs more research for better results.

Topical minoxidil helps treat hair loss in teens, but more research needed for safe options.

Androgens cause skin issues like acne and hair growth in women, often due to PCOS, and can be treated with medication and lifestyle changes.

Most treatments for hair loss in 1997 were not effective for most people, and maintaining hair growth was difficult.

The research confirmed that certain methods are reliable for standardizing Eclipta alba and ensuring its safety and quality in herbal products.

New factors in female hair loss include genetics, hormones, stress, and inflammation; future treatments should also focus on these areas and consider the patient's emotional well-being.

The study suggests fibrosing alopecia in a pattern distribution has distinct features and may vary by race.

Lower levels of certain genes in hair cells improve hair loss treatment outcomes.

Clinical signs of hyperandrogenism are related to female pattern hair loss severity, but biochemical markers are not.

Hair loss in men and women can be treated with medications and therapies, showing improvement after 6 months.

All women with Polycystic Ovary Syndrome (PCOS) in a study had at least one skin disorder, with the most common being excessive hair growth, acne, dark skin patches, hair loss, and oily skin.

Younger people are at a higher risk for Fibrosing Alopecia in a Pattern Distribution than previously thought, with common symptoms and possible involvement of mast cells in its development.

Hair loss, known as Androgenetic Alopecia, is often caused by hormones and can be diagnosed using noninvasive techniques. Treatments include topical minoxidil and oral finasteride, with new treatments being explored. There may also be a link between this type of hair loss and heart disease risk.

Follicular porokeratosis may be linked to diabetes and can lead to hair loss.

Manipulating cell cleanup processes could help treat hair loss.

New treatments for hair loss should target eight main causes and use specific plant compounds and peptides for better results.

Younger people may have a higher risk of hair loss due to poor nutrition and lifestyle.